Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Note 7 - Goodwill and Other Intangible Assets - Identifiable Intangible Assets Carrying Value (Details)

v3.7.0.1

Note 7 - Goodwill and Other Intangible Assets - Identifiable Intangible Assets Carrying Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets, Net	$ 36,358	$ 43,492
Finite-Lived Intangible Assets, Accumulated Amortization	(7,262)	(4,585)
RedPath [Member]
Finite-Lived Intangible Assets, Net	$ 43,011	47,468
Diagnostic Test, Thyroid [Member] \| Asuragen [Member]
Finite-lived intangible asset, useful life (Year)	9 years
Finite-Lived Intangible Assets, Net	$ 8,519	8,519
Diagnostic Test, Pancreas [Member] \| Asuragen [Member]
Finite-Lived Intangible Assets, Net		2,882
Diagnostic Test, Pancreas [Member] \| RedPath [Member]
Finite-lived intangible asset, useful life (Year)	7 years
Finite-Lived Intangible Assets, Net	$ 16,141	16,141
Diagnostic Test, Biobank [Member] \| Asuragen [Member]
Finite-Lived Intangible Assets, Net		1,575
Diagnostic Test, Barrett's RedPath [Member] \| RedPath [Member]
Finite-lived intangible asset, useful life (Year)	9 years
Finite-Lived Intangible Assets, Net	$ 18,351	18,351
CLIA Diagnostic Lab [Member]
Finite-lived intangible asset, useful life (Year)	2 years 109 days
Finite-Lived Intangible Assets, Net	$ 609	$ 609

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=idxg_RedPathMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxg_DiagnosticTestThyroidMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=idxg_AsuragenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxg_DiagnosticTestPancreasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxg_DiagnosticTestBiobankMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxg_DiagnosticTestBarrettsRedpathMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxg_CLIADiagnosticLabMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: